Literature DB >> 8822003

[Primary pulmonary malignant lymphoma of the T-cell type].

Y Sasaki1, F Yamagishi, K Suzuki, H Miyazawa, N Sugimoto, Y Abe.   

Abstract

A 65-year-old woman was referred to our department because of an abnormal shadow on the chest roentgenogram. The chest roentgenogram showed infiltrative shadows in the right middle and lower lung fields. The chest CT scan showed non-segmental infiltration with a hazy margin and a clear air bronchogram in the right S8 area. A transbronchial aspiration cytology specimen showed atypical lymphocytes, and a transbrochial lung biopsy specimen showed infiltration by atypical lymphocytes. Malignant lymphoma was suspected from the results of the biopsy examination, and a right middle and lower lobectomy was done. The pathological findings showed proliferative atypical lymphocytes in the alveolar and interstitial areas. Malignant lymphoma (diffuse medium cell type by LSG classification) was diagnosed and an immunohistiochemical examination showed monoclonal proliferation of T lymphocytes, which were positive for T lymphocyte surface marker (UCHL-1). Therefore, we believe this was a case of primary pulmonary malignant lymphoma of the T-cell type.

Entities:  

Mesh:

Year:  1995        PMID: 8822003

Source DB:  PubMed          Journal:  Nihon Kyobu Shikkan Gakkai Zasshi        ISSN: 0301-1542


  3 in total

1.  Bilateral pulmonary nodules as a manifestation of primary pulmonary T-cell lymphoma.

Authors:  Roberto Bernabeu Mora; Juan Miguel Sánchez Nieto; Andrés Nieto Olivares
Journal:  Int J Hematol       Date:  2009-07-17       Impact factor: 2.490

2.  Primary pulmonary T-cell lymphoma mimicking pneumonia: A case report and literature review.

Authors:  Lingyi Yang; Wei Feng; Cheng Chen; Xiuqin Zhang; Yehan Zhu; Wei Lei; Jian-An Huang
Journal:  Exp Ther Med       Date:  2016-04-21       Impact factor: 2.447

Review 3.  NK/T cell lymphoma of the lung: a case report and review of literature.

Authors:  P Laohaburanakit; K A Hardin
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.